CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-24 | RUCH JOSHUA Director | Sale | −1,805 | $160.45 | $290K | 26,658 |
| 2025-11-24 | RUCH JOSHUA Director | Sale | −2,268 | $161.16 | $366K | 24,390 |
| 2025-11-24 | RUCH JOSHUA Director | Sale | −147 | $162.04 | $24K | 24,243 |
| 2025-11-24 | RUCH JOSHUA Director | Sale | −2,016 | $158.40 | $319K | 147,268 |
| 2025-11-24 | RUCH JOSHUA Director | Sale | −6,279 | $159.28 | $1.0M | 140,989 |
| 2025-11-24 | RUCH JOSHUA Director | Sale | −8,944 | $160.45 | $1.4M | 132,045 |
| 2025-11-24 | RUCH JOSHUA Director | Sale | −11,234 | $161.16 | $1.8M | 120,811 |
| 2025-11-24 | RUCH JOSHUA Director | Sale | −728 | $162.04 | $118K | 120,083 |
| 2025-10-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +753 | 4,145 | ||
| 2025-10-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −388 | $136.54 | $53K | 3,757 |
| 2025-10-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −753 | 1,508 | ||
| 2025-10-29 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise | +3,874 | 5,594 | ||
| 2025-10-29 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −2,154 | $136.54 | $294K | 3,440 |
| 2025-10-29 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −4 | $136.75 | $547 | 3,436 |
| 2025-10-29 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Unit | −3,874 | 7,748 | ||
| 2025-09-30 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +1,246 | $32.67 | $41K | 10,001 |
| 2025-09-30 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −344 | $105.24 | $36K | 9,657 |
| 2025-09-30 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −387 | $106.86 | $41K | 9,270 |
| 2025-09-30 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,715 | $107.68 | $292K | 6,555 |
| 2025-09-30 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,152 | $108.67 | $234K | 4,403 |
Page 12 of 23 · 450 trades